ADI CEO exercises 10,000 options; sells 10,000 shares
Analog Devices (ADI) Form 4: Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $94.41 per share on 11/03/2025 and sold 10,000 common shares the same day at $234.95 per share pursuant to a 10b5-1 plan adopted on May 23, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Analog Devices (ADI) Form 4: Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $94.41 per share on 11/03/2025 and sold 10,000 common shares the same day at $234.95 per share pursuant to a 10b5-1 plan adopted on May 23, 2025.
After these transactions, he reported 163,640.462 shares held directly. He also reports 23,515 shares held indirectly by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. Following the option exercise, 74,637 options remain beneficially owned. The exercised option was fully vested, originally exercisable from 03/15/2021 and expiring on 03/11/2030.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $94.41 | $944K |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $94.41 | $944K |
| Sale | Comm Stock - $.16-2/3 value | 10,000 | $234.95 | $2.35M |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
Footnotes (3)
- F1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.
- F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
- F3. This option is fully vested.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ADI’s CEO Vincent Roche report on this Form 4?
Were the sales made under a 10b5-1 plan for ADI (ADI)?
What options remain after the exercise reported by ADI’s CEO?
What are the key dates for the exercised option?
AI-generated analysis. How Rhea-AI works. Not financial advice.